22 February 2019
photo of kava plant

Invitation to comment

The Office of Drug Control is seeking comments from interested parties on the options concerning the announcement by the Prime Minister, the Hon Scott Morrison MP, to put together a pilot program to ease some of the limitations on importation of kava into Australia for personal use.

The consultation seeks your feedback on:

  • A proposal to increase the quantity of kava that may be imported for personal use to 4kg
  • Approach to evaluate the pilot program after two years; and
  • The duration of the pilot program.

Consultation documents

Consultation: Pilot Program to ease restrictions on the importation of kava for personal use - PDF 249KB

Consultation: Pilot Program to ease restrictions on the importation of kava for personal use - DOCX 1059KB

Timetable

Interested parties should respond by close of business 22 March 2019.

Feedback will be released following consideration of submissions. (See 'What will happen').

About the consultation

On the 16 January 2019, the Prime Minister announced a pilot program would be put together to ease some of the restrictions on importation of kava, for personal use, into Australia.

The consultation paper has been prepared to enable interested parties to provide feedback on the pilot.

Content of submissions

Submissions may address any, or all, of the Pilot Program to ease restrictions on the importation of kava for personal use, or other identified issues.

In addition, submissions might include:

  • Suggested improvements.
  • Whether or not you support the proposal, including suggestions for alternatives.
  • An assessment of how the proposal will affect you.

How to submit

Complete the online consultation submission form to upload your submission in either pdf or word format.

Consultation submission form

Alternatively, hardcopy submissions with a printed cover sheet may be mailed to:

Office of Drug Control
Department of Health
GPO Box 9848
Canberra ACT 2601

Print version: Consultation submission cover sheet - DOCX 93KB

Enquiries

Any questions relating to submissions should be directed to the Drug Control Section by email to dcs@health.gov.au.

What will happen

All submissions will be placed on this website unless marked confidential or indicated otherwise in the submission form (see Privacy information).

The feedback on the consultation paper will be used to inform decisions on the pilot plan to ease some of the limitations on importation of kava into Australia for personal use.

Privacy information

  • The ODC collects your personal information in this submission in order to:
    • contact you if the ODC wants to seek clarification of issues raised in your submission or to check whether you consent to certain information that you have provided being made publicly available.
    • help provide context about your submission (e.g. to determine whether you are an individual or a director of a company or representing an interest group).
    • seek feedback about how the consultation was undertaken.
  • Please do not include personal information about other individuals in the body of your submission. Personal information in this context means information or an opinion about an individual whose identity is apparent, or can reasonably be ascertained, from the information or opinion.
  • More information on privacy can be found on our website.